Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Enhancing Food Safety: The Role of the Food and Drug Administration (2010) (ISBN 0309152739) Robert B. Wallace and Maria Oria, Editors; Committee on the Review of Food and Drug Administration's Role in Ensuring Safe Food; National Research Council


• Perspectives on Biomarker and Surrogate Endpoint Evaluation: Discussion Forum Summary (2011) (ISBN 0309163242) Alison Mack, Erin Balogh, and Christine Micheel, Rapporteurs; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Scientific Standards for Studies on Modified Risk Tobacco Products (2012) (ISBN 0309223989) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (2007) (ISBN 030910386X) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• Evolution of Translational Omics: Lessons Learned and the Path Forward (2012) (ISBN 0309224187) Christine M. Micheel, Sharly J. Nass, and Gilbert S. Omenn, Editors; Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine


• Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships: Workshop Summary (2008) (ISBN 0309108896) Miriam Davis, Sarah Hanson, Bruce Altevogt, Rapporteurs, Forum on Neuroscience and Nervous System Disorders, Institute of Medicine


• Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary (2009) (ISBN 0309131243) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Improving the Quality of Cancer Clinical Trials: Workshop Summary (2008) (ISBN 0309116686) Margie Patlak and Sharyl Nass, Rapporteurs


• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (2012) (ISBN 0309225493) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Assessing and Improving Value in Cancer Care: Workshop Summary (2009) (ISBN 0309138140) Adam Schickedanz, Rapporteur; Institute of Medicine


• Animal Models for Assessing Countermeasures to Bioterrorism Agents (2011) (ISBN 0309219094) Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents; National Research Council


• Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary (2011) (ISBN 0309212219) Diana E. Pankevich, Miriam Davis, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine